Newest Technologies

We manufacture mediches with new technology for better efficency.

Fair Prices

The prices are quite genuine and affordable.

Marketing Strategy

We provide all the marketing facilities of promotional materials.

High Customer Satisfaction

Timely services are our commitments and this makes us lead and give a customer satisfaction profile.

DNA-LABS Services has vast expertise and experience in extractables and leachables, particle analysis, container closure integrity, and performance and packaging/delivery systems among other methodologies. As a result of our understanding of materials and delivery systems and their compatibility with the drug product, we can assist our customers in designing studies and in navigating the challenging and evolving regulatory landscape.

About Us

About PCD Pharma Market in India

As we all aware of the fact that the pharmaceutical industry in India is growing at a very rapid rate. Since the industry is growing at high speed then it's obvious the related assets also growing. Pharmaceutical industry of India has main basic 2 aspects one is monopoly-based business and other is PCD based business. Business distributors, wholesalers of this industry in India now focus on getting monopoly things as the profit margins are very high as compared to other. Also with the help of a monopoly they can even excel their business to new heights.

LIQUID INJECTIONS

60% 60% Complete

DRY INJECTIONS

95% 95% Complete

CAPSULES

80% 80% Complete

TABLETS

100% 100% Complete

DRY SYRUPS

70% 70% Complete

Latest News

Desi pharma companies top in biosimilars globally

29
Oct , 2018

Biosimilars are approved versions of biopharmaceuticals ó complex medicines manufactured using live organisms, as against conventional drugs that are based on chemical composition.

Read More

Diviís Laboratories shares rally over 11% post Q2 results

29
Oct , 2018

The scrip was trading 11.75 per cent up at Rs 1,401.25 at around 9.35 am (IST).

Read More

Big pharma companies set to return to double-digit growth this fiscal: Crisil

29
Oct , 2018

Revenue from US grew 7 per cent in the first quarter of this fiscal.

Read More

High drug prices due to unreasonable margins of companies: CCI

29
Oct , 2018

??The CCI also prescribed various ways to reduce the anti-trade practices in the policy paper.

Read More

Big pharma companies plan cheaper alternatives for Ayushman Bharat

29
Oct , 2018

Integration of the existing Pradhan Mantri Jan Aushadhi Pariyojana (PMBJP), which supplies generic medicines at around 50% discount will strengthen Ayushman Bharat.

Read More

Is your portfolio anaemic? Careful, the pharma pill may not help defend against vulnerability

29
Oct , 2018

Brokerages turned cautious on the sector just ahead of September quarter earnings.

Read More
PHP Contact Form With Captcha And Validation - reusable form

Contact With Us